Verition Fund Management LLC Neuronetics, Inc. Transaction History
Verition Fund Management LLC
- $19.9 Billion
- Q1 2025
A detailed history of Verition Fund Management LLC transactions in Neuronetics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 120,097 shares of STIM stock, worth $528,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120,097Holding current value
$528,426% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding STIM
# of Institutions
108Shares Held
19.5MCall Options Held
96.2KPut Options Held
58.4K-
Vanguard Group Inc Valley Forge, PA2.31MShares$10.1 Million0.0% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$7.65 Million1.44% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.42MShares$6.24 Million0.01% of portfolio
-
Ikarian Capital, LLC Dallas, TX1.1MShares$4.84 Million0.57% of portfolio
-
Masters Capital Management LLC Atlanta, GA1MShares$4.4 Million0.19% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $119M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...